House Ways & Means Chairman Rep. Richard Neal (D-MA) said Tuesday (Feb. 12) that he asked HHS Secretary Alex Azar to consider making prescription drug makers pay rebates to Medicare if they hike Part B drug prices faster than the rate of inflation. However, it’s not clear whether that rebate policy is compatible with the administration’s approach of eliminating rebates in Medicare Part D. In 2017, Congressional Medicare advisers suggested forcing drug companies to pay such inflationary rebates in Part...